ClinicalTrials.Veeva

Menu

Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI

S

Sakarya University

Status

Unknown

Conditions

ST Elevation Myocardial Infarction
Myocardial Infarction

Treatments

Other: Ultrasound beams Philips HD11 XE®

Study type

Interventional

Funder types

Other

Identifiers

NCT02299609
CCTSAU1400

Details and patient eligibility

About

Successfully perfused STEMI patients will receive routine transthoracic echocardiography qid for 4 days or placebo. Myocardial function and infarct size will be evaluated at 3 and 6 months.

Full description

Patients who had acute STEMI and successfully reperfused by either thrombolytic therapy or primary angioplasty and stenting will be included this study.

A basal routine echocardiography will be obtained in all patients after reperfusion therapy. Thereafter, patients will be divided into two groups: 1.Treatment group will receive transthoracic echocardiography using Philips HD11 XE ® for 30 minutes qid for 4 days. 2. Placebo group will have the same Philips HD11 XE ® echo transducer applied for the same time and duration on their chest but with the ultrasound turned-off. Detailed left and right ventricle function as well as performance index and stress-strain imaging will be obtained and analyzed at 3 and 6 months.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-Patients presenting within 12 hours of their first ST- elevation myocardial infarction that is successfully reperfused; and completed baseline echocardiographic evaluation and accepted participation in the study

Exclusion criteria

Patients:

  • With prior ST- elevation myocardial infarction
  • Patients presenting >12hrs
  • Not successfully reperfused
  • Not completed baseline ECHO evaluation,
  • Not accepting participation in the study

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

100 participants in 2 patient groups

Beam Receiver
Active Comparator group
Description:
Philips HD11 XE® 30 min qid x 4 days
Treatment:
Other: Ultrasound beams Philips HD11 XE®
Beam Non-Receiver
Sham Comparator group
Description:
Philips HD11 XE® (ultrasound turned-off) 30 min qid x 4 days
Treatment:
Other: Ultrasound beams Philips HD11 XE®

Trial contacts and locations

1

Loading...

Central trial contact

Ramazan Akdemir, MD; Ramazan Akdemir, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems